The Carlyle Group Inc. (CG)
| Market Cap | 14.62B |
| Revenue (ttm) | 4.74B |
| Net Income (ttm) | 1.02B |
| Shares Out | 360.88M |
| EPS (ttm) | 2.77 |
| PE Ratio | 14.62 |
| Forward PE | 10.36 |
| Dividend | $1.40 (3.45%) |
| Ex-Dividend Date | Feb 21, 2025 |
| Volume | 2,109,140 |
| Open | 40.63 |
| Previous Close | 40.76 |
| Day's Range | 40.49 - 41.49 |
| 52-Week Range | 33.02 - 57.50 |
| Beta | 1.84 |
| Analysts | Hold |
| Price Target | 47.79 (+17.88%) |
| Earnings Date | May 8, 2025 |
About CG
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid ventu... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for CG stock is "Hold." The 12-month stock price forecast is $47.79, which is an increase of 17.88% from the latest price.
News
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”), Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and Beacon Parent Holdings...
Carlyle CEO Harvey Schwartz says actively looking for investments
Harvey Schwartz, CEO of the Carlyle Group, says his firm is actively seeking opportunities to deploy some of the firm's $80 billion in free capital into new investments.
Carlyle Group sells full stake in India's PNB Housing, Moneycontrol says
U.S. private equity group Carlyle Group has sold its entire 10.44% stake in India's PNB Housing Finance via block deals, business news website Moneycontrol reported on Thursday, citing a termsheet.
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
Acentra Health awarded $27.5 million contract from California Medicaid to continue providing mental health preadmission screenings for long-term care.
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Socially Determined, a social risk analytics and solutions company leading the integration of health and social care, and Acentra Health, a technology an...
A recession is 'certainly on the table,' says Carlyle Group CEO Harvey Schwartz
Carlyle Group CEO Harvey Schwartz warned that a recession is a possibility. But he told Bloomberg Television it was too early to make a judgment, and there could be a rebound.
Carlyle Group CEO Talks Fed, China-US and Trump Tariffs
Previously Carlyle Group CEO Harvey Schwartz told investors to “buckle up a bit” for more market volatility as Trump Administration tariffs kick in, now more than two weeks since those tariffs kicked ...
Carlyle's Jeff Currie Sees Downside Risk on Oil That Could Hit Shale
Jeff Currie, Chief Strategy Officer for Energy Pathways at Carlyle, says there's a lot of downside risk, with oil and commodities “in the cross-hairs” of the trade war. “I think oil probably has this ...
The potential for oil to overshoot to the downside is pretty significant: Carlyle's Jeff Currie
Jeff Currie, Carlyle chief strategy officer of energy pathways, joins 'Squawk Box' to discuss the impact of President Trump's sweeping new tariffs on the energy sector, latest oil price trends, impact...
UK's Energean terminates Carlyle deal
UK-based Energean said on Friday it was terminating its deal with private equity fund Carlyle for some of the gas producer's assets due to pending regulatory approvals in Italy and Egypt.
Carlyle seeks buyers for Colombian oil producer
Private equity group Carlyle is seeking a buyer for its Colombian oil producer SierraCol for around $1.5 billion, according to people with knowledge of the matter.
SoftBank Group to Acquire Ampere Computing
TOKYO & SANTA CLARA, Calif.--(BUSINESS WIRE)--SoftBank Group Corp. (TSE: 9984, “SoftBank Group”) today announced that it will acquire Ampere® Computing, a leading independent silicon design company, i...
Carlyle's Currie on Canada Tariffs, Energy Security, Oil, Aluminum and Copper Prices
Jeff Currie, Carlyle Chief Strategy Officer of Energy Pathways, talks about the oil market outlook, the need for energy security and the US increasing tariffs on steel and aluminum from Canada. He spe...
Carlyle CEO Says ‘Buckle Up' as Trump Tariffs Take Hold
Carlyle Group CEO Harvey Schwartz told investors to “buckle up a bit” for more market volatility as Trump Administration tariffs kick in. Schwartz spoke Tuesday at the Bloomberg Invest conference in N...
Carlyle to ramp up pace of IPOs as it eyes up to $5 billion of exits in 2025
Carlyle Group expects to take more of its portfolio companies public this year and will not shy away from large leveraged buyouts, betting on a rebound in U.S. dealmaking this year, its heads of priva...
NSM Insurance Group Announces Definitive Agreement for New Mountain Capital to Acquire Its U.S. Commercial Insurance Division
CONSHOHOCKEN, Pa. , Feb. 24, 2025 /PRNewswire/ -- NSM Insurance Group ("NSM"), a global specialty insurance provider, announced today it has signed a definitive agreement to sell its U.S. commercial i...
Big 4 Private Equity Firms In Brighter Mood; Falling Investment In Biotech
Surging revenue from asset management businesses appeared to lift the spirits of private equity's Big Four firms. The middle market drove the increase in the monetization of portfolio company investme...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
NEW YORK , Feb. 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by bluebird bio, Inc. (NASDAQ: BLUE) and its board of directors concerning the proposed ac...
bluebird bio Stock Alert - Kehoe Law Firm, P.C. Investigating the Fairness and Adequacy of the Proposed Acquisition of bluebird bio by Investment Firms in Collaboration with Biotech Execs
PHILADELPHIA, PA / ACCESS Newswire / February 21, 2025 / Kehoe Law Firm, P.C. is investigating potential claims on behalf of investors of bluebird bio (NASDAQ:BLUE) regarding the adequacy and fairness...
Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch
Gene therapy maker Bluebird bio said on Friday it would be taken private by Carlyle and SK Capital Partners, ending its tumultuous journey in the public markets as it struggled with a severe cash crun...
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment ...
Higher Fee Revenues, Brighter Outlook Boost Mood Of Private Equity's Big 4
Record revenues from management fees and a brighter outlook for M&A in the year ahead helped private equity's Big Four close 2024 on a high note. The average net positivity score for the four largest ...
Acentra Health Employees Provide Over 3,000 Hours of Volunteer Work to Promote Healthier Communities
MCLEAN, Va., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial health...